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INTRODUCTION 
            
Among all congenital malformations, congenital heart disease is a 
relatively common problem with an incidence of 5-8 in every 1000 live 
births
1-9
. Of this 25% will have critical congenital heart disease.
9-12
 
Congenital heart disease account for about 10% of infant deaths and 
about half of deaths due to congenital malformations in developed 
countries
2
. Now a days even complex congenital heart disease can be 
treated with the appropriate surgical or catheter intervention
13
. Early 
diagnosis of congenital heart disease is important for a good clinical 
outcome. Unrecognized or delayed diagnosis of some severe congenital 
heart diseases can lead to cardiac failure, cardiovascular collapse, and 
even death
14-18
. 
         However diagnosis of congenital heart disease in the first few days 
of life is difficult because of an initial lack of specific clinical signs
2
. 
Clinical examination remains the most frequently used method to 
diagnose congenital heart disease in new borns
19-22
. In particular the 
presence of a heart murmur can raise the suspicion of congenital heart 
disease. But routine neonatal clinical examination fails to detect more 
than 50% of infants with congenital heart disease 
23
. More than 55% of 
them have no murmur
24
 and most of them are discharged before a 
 
 
diagnosis can be made and readmitted with severe heart failure or 
cardiovascular collapse
23
. 
Therefore there is a need for effective screening program for early 
detection of congenital heart disease. This disease would be ideally suited 
for a screening program if simple and reliable method were available. 
Recently pulse oximetry has been suggested as a screening tool for 
detection of congenital heart disease especially cyanotic and critical 
congenital heart diseases in asymptomatic new born.
10,11,26
 These babies 
have a decreased oxygen saturation due to right to left shunt which is 
either intracardiac or at Patent ductus arteriosus (PDA) level. This can be 
measured by pulse oximetry.  
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
CARDIAC DEVELOPMENT 
 Knowledge of the mechanisms of cardiac development is 
necessary in understanding congenital heart defects and developing 
strategies for prevention. 
EARLY CARDIAC MORPHOGENESIS 
 The fetal heart is morphologically developed at 8
th
 week 
of gestation
5,28
. First identifiable cardiac precursors are angiogenetic cell 
clusters arranged on both sides of the embryos central axis. These clusters 
form paired cardiac tube by 18 days of gestation. The paired tubes fuse in 
the mid line on the ventral surface of the embryo to form the primitive 
heart tube by 22 days. As early as 20-22 days, before cardiac looping, the 
embryonic heart begins to contract and exhibits phases of the cardiac 
cycle that are surprisingly similar to those of in a mature heart
29
. 
Morphologist have identified segments of the heart tube that were 
believed to correspond to structures in a mature heart, the sinus venosus 
and atrium (right and left atria),the primitive ventricle (left ventricle),the 
bulbus cordis (right ventricle) and the truncus arteriosus (aorta and 
pulmonary artery). 
 
 
 
 
CARDIAC LOOPING 
 Between day 23-28 the heart tube is making a loop to the right 
moving the atrial portion cranially, the ventricular part caudally and the 
out flow tract remains positioned cranially
30
. When something goes 
wrong at this stage, the results can be a physiologically corrected 
transposition of the great arteries or an incorrect relation between the left 
atrium and aorta causing an AV plane displacement resulting in a double 
inlet left ventricle or a double outlet right ventricle. 
 The normal asymmetry caused by the rightward rotation 
determines the situs of the fetus and normal situs is called situs solitus. If 
the normal asymmetry does not occur, the result can be situs inversus 
(mirror image of the normal atrial relationship), situs ambiguous or left or 
right atrial   isomerism (bilateral left sided or bilateral right sided atria).
29
 
 
 
 
 
 
 
 
 
 
 
 
 
             
 The chamber differentiation then occurs between days   27-37 and 
can be divided into four parts beginning with the development of aortic 
arches. There are originally 6 paired branchial arches developed. They 
form at different times and regress in a complex way. The first one 
develops further to become vessels in the face and carotid arteries. Only 
the 6 th remains complete as the aortic arch. Interruptions here  can result 
in a vascular ring compressing the trachea, like double aortic arch, right 
aortic arch with left ligamentum arteriosum or pulmonary artery sling 
(aberrant left pulmonary artery arising from the superior surface of the 
right pulmonary artery and coursing between the trachea and 
esophagus).
29 
CARDIAC SEPTATION 
                    Septation of the ventricles begins at about embryonic day 25. 
The muscular part of inter-ventricular septum grows from the bottom 
(apex) to the top where the large part is constituted of the 
perimembranous septum. Naturally defects have results in muscular VSD 
or perimembranous VSD. 
 Septation of the atria begins at 30 days of embryonic life. 
It grows from both sides (septum primum) leaving a patent foramen 
ovale(PFO) open in the middle. A second septum, septum secondum is 
 
 
then growing down to the right of the septum primum. The secondum 
part does not cover the foramen ovale during fetal life, because it is 
important that the PFO remains open until after birth
28,29
. 
 Lastly the septation of the out flow vessel is completed 
between day 35-42. The out flow septation from one into two, is formed 
as a spiral and it something goes wrong here, the result can be a common 
atrial trunk (truncus arteriosus), aorta pulmonary window (APW), 
transposition of the great arteries (the out flow wall is growing straight 
instead of spiral formed causing parallel outflows), tetralogy of fallot (the 
wall is shifted rightwards) or hypoplastic left heart syndrome(HLHS) 
when the wall is shifted leftwards. The conducting system develops from 
day 35 to birth and the coronary circulation between day 48-51. 
Innervation of the heart takes place from day 49 to birth. Formation of the 
AV valves occurs by excavation and cushions in the ventricles and 
semilunar valves of excavations and growth in the pulmonary artery and 
aorta. Incomplete formation of the valves can result in Ebstein anomoly, 
stenosis or atretic valves. 
 
 
 
 
 
 
FETAL CIRCULATION 
In the fetal circulation, the right and left ventricles exist in a 
parallel circuit, as opposed to the series circuit of a newborn or adult. In 
the fetus, the placenta provides for gas and metabolite exchange. The 
lungs do not provide gas exchange, and vessels in the pulmonary 
circulation are venous constricted. Three cardiovascular structures unique 
to the fetus are important for maintaining this parallel circulation: the 
ducuts venous, foramen ovale, and ducuts arteriosus.  
Oxygenated blood returning from the placenta flows to the fetus 
through the umbilical vein with a PO2 of about 30-35 mm Hg. 
Approximately 50% of the umbilical venous blood enter the hepatic 
circulation, whereas the rest bypasses the liver and joins the inferior vena 
cava via the ductus venous, where it partially mixed with poorly 
oxygenated inferior vena cava blood derived from the lower part of the 
fetal body. This combined lower body plus umbilical venous blood flow 
(PO2 of = 26-28 mm Hg) enters the right atrium and is preferentially 
directed across the foramen ovale to the left ventricle and is ejected into 
the ascending aorta. Fetal superior vena cava blood, which is 
considerably less oxygenated (PO2 of 12-14 mm Hg), enters the right 
atrium and preferentially traverses the tricuspid valve, rather than the 
foramen ovale, and flow primarily to the right ventricle.                                
 
 
FETAL CIRCULATION 
 
                                             
 
 
From the right ventricle, the blood is ejected into the pulmonary 
artery. Because the pulmonary arterial circulation is vasoconstricted, only 
about 10% of right ventricular outflow enters the lungs. The major 
portion of this blood (which has a PO2 of = 18-22 mm Hg) bypasses the 
lungs and flows through the ductus arteriosus into the descending aorta to 
perfuse the lower part of the fetal body, after which it returns to the 
placenta via the two umbilical arteries. Thus, the upper part of the fetal 
body (including the coronary and cerebral arteries and those to the upper 
extremities) is perfused exclusively from the left ventricle with blood that 
has a slightly higher PO2 than the blood perfusing the lower part of the 
fetal body, which is derived mostly from the right ventricle. Only a small 
volume of blood from the ascending aorta (10% of fetal cardiac output) 
flows across the aortic isthmus to the descending aorta.
109
      
  
       
 
 
 
 
 
 
 
 
THE TRANSITION FROM FETAL TO NEONATAL CIRCULATION 
  With birth, the function of gas exchange is transferred from the 
placenta to the lungs, and therefore from the systemic circulation to the 
pulmonary circulation. The venous and arterial circulations are separated, 
and not only are the fetal shunts unnecessary, but their persistence may 
lead to circulatory compromise. The transition from the fetal to the 
neonatal circulation thus includes elimination of the placental circulation, 
lung expansion, and increase in lung blood flow so that the entire cardiac 
output can be accommodated, and closure of the foramen ovale, ductus 
arteriosus, and ductus venosus.  
For most congenital structural heart disease, the fetal shunt 
pathways allow redistribution of ventricular blood flows so that systemic 
blood flow is adequate and fetal growth and developments are usually 
normal. Uncomplicated VSDs do not alter the circulation significantly in 
either the fetus or immediate newborn period, with the important 
exception of premature infants. With severe left heart obstruction, the 
burden of systemic and pulmonary blood flow is transferred to the fetal 
right ventricle, with reversal of blood flow at the foramen ovale, and 
systemic blood flow almost entirely transmitted via the ductus arteriosus. 
This "ductal-dependent" systemic circulation is poorly tolerated in the 
newborn, because normal closure of the ductus arteriosus progressively 
 
 
decreases systemic blood flow and progresses to circulatory failure and 
shock. Severe right heart obstruction is also well tolerated in the fetus, 
because the combined fetal cardiac output  can be transferred to the aorta, 
with the ductus arteriosus supplying predominantly lung blood flow. 
After birth, such "ductal-dependent" pulmonary blood flow can lead to 
critically low levels of pulmonary blood flow and severe cyanosis with 
closure of the ductus arteriosus. 
 An understanding of fetal hemodynamics and the acute and 
chronic changes that occur with transition to the newborn circulation are 
important for the care of normal newborns and are crucial to the 
recognition, diagnosis, and management of the newborn with significant 
congenital heart disease.
109
 
CAUSES OF CONGENITAL HEART DEFECTS
31
  
        The etiology is multifactorial including  
 Genetic factors (chromosomal disorders, single – gene disorders and 
polygenic disorders)  
 Environmental risk factors (smoking, paints, varnishing, pesticides, 
solvents and hair dye).   
 Teratogenic drugs 
       Alcohol (septal defects) 
       Diazepam, Corticosteroids, Hydantoin (pulmonary and aortic stenosis), 
 
 
       Lithium, Trimethadione (transposition of the great arteries, 
       Tetralogy of fallot, hypoplastic left heart syndrome),  
       Folate antagonists, thalidomide (conotruncal abnormalities), 
       Retinoic acid (conotruncal and aortic arch abnormalities) 
 Maternal disease increasing the risk are Epilepsy (pulmonary stenosis), 
poorly controlled Diabetes (tetralogy of Fallot, truncus arteriosus, double 
outlet right ventricle), poorly controlled Phenylketonuria (Tetralogy of 
Fallot), Systemic Lupus Erythematosus (AV – block grade III). 
 Infections such as Rubella during the first trimester (Patent Ductus 
Arteriosus and peripheral pulmonary artery stenosis) and other viral 
infections (Coxsackie and HIV).  
 
STRUCTURAL CARDIAC DEFECTS  
They are classified into  
(i) Acyanotic congenital heart defects. 
(ii) Cyanotic congenital heart defects.  
 
 
 
 
 
 
CLINICAL PRESENTATIONS OF CONGENITAL HEART 
DISEASE IN THE NEONATE 
The timing of presentation and accompanying symptomatology 
depend on 
 Nature and severity of the anatomic defect.  
 The alterations in cardiovascular physiology secondary to the 
effects of the transitional circulation. (closure of the ductus 
arteriosus and the fall in pulmonary vascular resistance). 
In the first few weeks of life, the many heterogenous forms of heart 
diseases were presented in a limited number of ways.  They are  
 Heart murmur 
 Cyanosis  
 Congestive  heart failure   
 Arrhythmia 
HEART MURMUR   
 Heart murmurs are not uncommonly heard when 
examining neonates. Estimates of the prevalence of heart murmurs in 
neonates vary widely from <1% to 50%> depending on the study. 
Murmurs heard in newborns in the first days of life are often associated 
with structural heart disease of some type, and therefore may need further 
 
 
evaluation, particularly if there are any other associated clinical 
symptoms. 
 Pathologic murmurs tend to appear at characteristic ages. 
Semilunar valve stenosis (systolic ejection murmurs) and atrioventricular 
valvar insufficiency (systolic regurgitant murmurs) tend to be noted very 
shortly after birth, on the first day of life. In contrast, murmurs due to left 
to right shunt lesions (systolic regurgitant ventricular septal defect 
murmur or continuous PDA murmur) may not be heard until the second 
to fourth week of life, when the pulmonary vascular resistance has 
decreased and the left-to-right shunt increase. Therefore, the age of the 
patient when the murmur is first noted and the character of the murmur 
provide important clues to the nature of the malformation.
 107
   
CYANOSIS  
 Cyanosis (bluish tinge of the skin and mucous 
membranes) is one of the presenting signs of congenital heart disease in 
the neonate. Cyanosis usually indicates underlying hypoxemia 
(diminished level of arterial oxygen saturation). Depending on the 
underlying skin complexion, clinically apparent cyanosis is usually not 
visible until there >3 g/dl of desaturated hemoglobin in the arterial 
system. Therefore, the degree of visible cyanosis depends on both the 
severity of hypoxemia (which determines the percent of oxygen 
 
 
saturation) as well as the hemoglobin concentration. For example, 
consider two infants with similar degrees of hypoxemia each having an 
arterial oxygen saturation of 85%. The polycythemic newborn 
(hemoglobin of 22g/dL) will have 3.3 g/dL (15% of 22) desaturated 
hemoglobin and be more easily appreciated to be cyanotic than the 
anemic infant (hemoglobin of 10 g/dL) who will only have 1.5 g/dL (15% 
of 10) deasaturated hemoglobin. True central cyanosis should be a 
generalized finding (i.e., not acrocyanosis, blueness of the hands and feet 
only, which is a normal finding in a neonate).
 107
 
 
CONGESTIVE HEART FAILURE(CHF) 
 CHF in the neonate is a Clinical diagnosis made on the 
basis of the existence of certain signs and symptoms rather than on 
radiographic or laboratory findings (although these may be supportive 
evidence for the diagnosis). In early stages, the neonate may be 
tachypneic and tachycardiac, with an increased respiratory effort, rales, 
hepatomegaly, and delayed capillary refill. In contrast to adults, edema is 
rarely seen. Diaphoresis, feeding difficulties, and growth failure may be 
present. Finally, CHF may present acutely with cardiorespiratory 
collapse, particularly in “left-sided” lesions. Hydrops fetalis is an extreme 
form of intrauterine CHF.
 107
      
 
 
Critical Congenital Heart Disease (CCHD)  
1. All babies with duct dependent circulation are included in this group. But 
a baby can have a life threatening heart defect and not being defined as 
duct dependent. “Paediatric cardiologists commonly defines” CCHD as a 
condition that either is duct dependent or requires surgery or intervention 
during the first month of life to survive.
32,33
 
2.  Mellander and Sunnegardh use the definition of critical as “a heart defect 
that most likely would have caused circulatory collapse or death if 
surgery or catheter intervention had not been performed before 2 months 
of age”.12,34.   
3. Sendelbach et al. defined CCHD by listing diagnoses, not severity or 
time before death or intervention and include tetralogy of Fallot, 
pulmonary atresia, truncus arteriosus, transposition of the great arteries, 
total anomalous pulmonary venous return and tricuspid atresia in the 
cyanotic group and coarctation of the aorta, critical aortic stenosis, 
interrupted aortic arch and hypoplastic left heart syndrome in the left 
heart obstructive group
6
.     
DUCT DEPENDENT LESIONS 
In certain conditions the presence of patent ductus is essential for 
existence of life. In the absence of blood flow in the ductus the child will 
 
 
die. This is called an obligatory PDA. The conditions that require a patent 
ductus are as follows
108
 
1. Ductus is the only means of the pulmonary blood flow 
 Pulmonary atresia with intact ventricular septum 
 Tricuspid atresia with intact septum 
2. Ductus is the only means of the systemic blood flow 
 Aortic atresia 
 Preductal coarctation of aorta 
 Hypoplastic left heart syndrome 
  3. Ductus is the means of bidirectional blood flow 
 Transposition of great arteries with intact septum 
CUSTOMARY PRACTICE  
 Timely diagnosis of congenital heart disease (CHD) is challenging 
but critical.  Children with such life threatening defects may not initially 
have symptoms or the symptoms may be vague, and the condition is not 
detected in the majority of cases 
23, 36, 37.
 
Strategies that have been suggested to improve early detection of 
CHD include prenatal ultrasound screening, prolonged hospital stay after 
delivery, one or more post discharge examinations during the first or the 
following two weeks of life, and training clinicians to detect “silent” 
CHD. However, all these strategies are cumbersome and costly and their 
 
 
value is doubtful. Despite the apparent need, until recently, there were no 
other means for early detection of CHD 
14,39,40.
.  
Since the late 1980s, prenatal ultrasound has been used to screen 
for congenital anomalies. An anatomic ultrasound is typically performed 
at 18 to 20 weeks gestation. During this process many, but not all, cases 
of CHD can be identified by a methodical scan.
41
    
Prenatal ultrasound, performed by those with specific training in 
congenital heart disease, can identify a variety of CHD lesions. However, 
numerous studies have reported that even when fetal ultrasound is 
routinely performed during pregnancy, fewer than 50% of cases of CHD 
are identified
42-47
.  
There are several factors that might account for the relatively low 
prenatal CHD detection rate. The quality of anatomic ultrasounds varies 
considerably.  A number of medical professionals, including radiologists, 
perinatologists, and general obstetricians with varying degrees of training, 
as well as technicians, perform these ultrasounds.  In addition to concerns 
about the quality, there may be limited access to prenatal ultrasound.  The 
availability of anatomic ultrasound is likely to be particularly limited in 
certain low socioeconomic status groups. Therefore, although prenatal 
ultrasound plays an important part in the timely identification of CHD, 
 
 
population based data demonstrate that this methodology by itself is 
insufficient to identify a high proportion of cases.
48-52 
Screening for congenital heart disease by primary care providers is 
currently accomplished by physical examination and on subsequent 
nursery visits. Supplemental tests, including electrocardiograms, pulse 
oximetery, and chest radiographs, are often obtained in suspicious 
cases.
26
  
Skilled physical examination, a sensitive and specific screening 
tool in older children, does not always distinguish between neonates with 
and without congenital heart disease.
54,55
  Hypoxemia is difficult to detect 
in newborns, and the transitional circulation masks important clinical 
findings such as absent femoral pulse while the ductus arteriosus remains 
patent. Perhaps most importantly, physical examination skills are on the 
decline in current trainees.
56
  
Heart murmurs have a prevalence of between 0.6% and 4.2% in 
newborns and are mistakenly considered a hallmark of heart disease.
24,57
 
They often do not accompany critical heart defects, particularly those 
with valve Atresia and transposition. Flow murmurs of the transitional 
circulation, transient tricuspid regurgitation, and small ventricular septal 
defects are common and of no clinical importance in newborns. 
Conversely, murmurs of many important complex heart defects, such as 
 
 
tricuspid atresia with ventricular septal defect, double – outlet right 
ventricle, and total anomalous pulmonary venous return, emerge only 
after the decline in pulmonary resistance and after neonatal discharge and 
are often heard but not considered pathological. Practicing pediatricians 
currently have limited experience in discriminating innocent from 
pathological murmurs. In a contemporary series in which echo- 
cardiography was performed to evaluate for possible heart disease based 
on suspicious physical examination, fewer than 15% of subjects were 
found to have significant congenital heart disease
53
. 
Clinical experience and epidemiological observations suggest that 
although physical examination, electrocardiogram, and chest radiograph 
are useful identifying many cases of serious congenital heart disease 
postnatally, they do not have sufficient sensitivity and specificity to 
detect all cases. Echocardiography, although an essential diagnostic tool, 
has serious limitations as a universal screening tool, particularly its cost.
55 
When used positive results (usually related to the transitional circulation) 
of either false of clinically benign diagnoses (eg, small muscular 
ventricular septal defects). In addition, there may be an inadequate supply 
of trained personnel who could perform this screening with a reasonable 
degree of accuracy. Therefore, there is considerable interest in improving 
the detection of CHD with novel diagnostic techniques.
 105
 
 
 
PULSE OXIMETRY AND DETECTION OF CHD 
A common feature of many forms of congenital heart disease is 
hypoxemia. Hypoxemia results from the mixing of systemic and venous 
circulations or parallel circulations as one might see in dextro-
transposition of the great arteries. Hypoxemia may result in obvious 
cyanosis. However, generally, 4 to 5 g of deoxygenated hemoglobin is 
needed to produce visible central cyanosis, independent of hemoglobin 
concentration
58
. For the typical newborn with a hemoglobin concentration 
of 20 g / dL, cyanosis will only be visible when arterial oxygen saturation 
is <80%; if the infant only has a hemoglobin concentration of 10 g / dL. 
The saturation must be <60% before cyanosis is apparent.  Importantly, 
those children with mild hypoxemia, with arterial oxygen saturation of 
80% to 95%, will not have visible cyanosis. Moreover, the identification 
of cyanosis is particularly problematic in black and Hispanic neonates 
because of skin pigmentation
58
.  
The majority of CHD lesions present with some degree of 
hypoxemia in the newborn period. The below table demonstrates the 
frequency of the most common forms of CCHD based on data from the 
Metropolitan Atlanta Congenital Birth Defects Surveillance Program and 
the likelihood of having some degree of hypoxemia in the newborn 
period. To improve timely detection of CHD, a number of investigators 
 
 
have proposed that pulse oximetry be considered as a complementary 
modality to the newborn physical examination
11,73
. 
LESION PREVALENCE / 
10000 LIVE BIRTH 
HYPOXEMIA 
OUTFLOW TRACT DEFECTS    
Tetralogy of fallot  6.1 MOST 
D-transposition of the great arteries  4.0 ALL 
Double – outlet right ventricle  1.7 SOME 
Truncus arteriosus  1.0 ALL 
TAPVC  1.2 ALL 
Ebstein anomaly  0.6 SOME 
RIGHT OBSTRUCTIVE DEFECTS    
Tricuspid atresia  0.5 ALL 
Pulmonary atresia with intact septum  0.8 ALL 
Pulmonary stenosis, atresia  6.3 SOME 
LEFT OBSTRUCTIVE DEFECTS    
Hypoplastic left heart  3.3 ALL 
Coarctation of the aorta  4.7 SOME 
Aortic arch atresia or hypoplasia  1.0 SOME 
Critical aortic valve stenosis  1.6 UNCOMMON 
OTHER MAJOR HEART DEFECTS  12.4 SOME 
Pulse oximetry is used routinely in the assessment of young 
children in neonatal intensive care units and emergency departments and 
has been proposed as an adjunct to the assessment of the new born in the 
delivery room
62
(Neonatal Resuscitation Protocal 2010 guidelines). As 
such, some have proposed  that pulse oximetry be considered as  a vital 
sign equivalent in importance to pulse, respirations, and blood pressure
63
. 
 
 
PULSE OXIMETRY SCREENING 
Every baby is cyanotic until birth. The first breaths and increasing 
pulmonary circulation induce a rapid rise in pulse oximetry oxygen 
saturation (Spo2).  
PULSE OXIMETRY IN THE NORMAL NEW BORN 
The mean preductal (right hand) and postductal (foot) SpO2 of 
healthy newborns at the age of 2 min has been shown to be 73% (range 
44–95%) and 67% (34–93%), respectively. In that study of 50 newborns, 
these values increased at 10 min to 92% (65–99%) and 89% (62–99%), 
respectively, and in every newborn both measurements reached 95% 
within 1hr. The reduction in the difference between preductal and post 
ductal measurements reflects the diminishing ductal right to left shunt. 
However, a slower disappearance of the shunt has been seen in 4–5% 
among larger populations. Thus, use of SpO2 for screening is not 
practical before the age of 1–2 h. Thereafter, the normal baseline SpO2 is 
quite stable at about 98%, except for short periods when it is lower, in 
particular during feeding and apnoeic spells
10, 64-66
. 
O’Brien and colleagues have defined reference data for oxygen 
saturation in healthy full term infants during their first 24 hours of life. 
The median value at 20 to 24hours of life (97.8%) is similar to the results 
for healthy full-term infants between 2 and 7 days of age (97.6%).Other 
investigators have reported similar results
66-69
. 
 
 
PULSE OXIMETRY IN CONGENITAL HEART DISEASE 
Byrne et al found that cyanotic CHD with obligatory or mixing 
cyanosis was associated with either a generally low level of SpO2  
<88%.
70
 However, a pure left to right shunt does not affect systemic 
oxygenation and is not detectable by pulse oximetry. These phenomena 
form the basis of pulse oximetry screening for CHD. 
AGE AT PULSE OXIMETRY SCREENING 
Because newborns with critical congenital heart disease (CCHD) 
may have clinical deterioration in the first 48 hours of life, one would 
ideally use oximetry screening soon after delivery. However, arterial 
oxygen saturation varies considerably in the first 24 hours, with many 
healthy newborns having arterial saturations of less than 95%. As such, 
oximetry screening before 24 hours of life can result in a significant 
number of false-positive results. A study from the United Kingdom 
reported that the false-positive rate was as high as 5% when oximetry 
screening was performed in the first 24 hours compared with 1% at the 
time of hospital discharge
71
. Therefore, to achieve an acceptable 
specificity, testing 24 hours after birth would appear to be the most 
reasonable strategy. 
 
 
 
 
CUT-OFF SATURATION 
The establishment of a cutoff threshold for an abnormal SpO2 is 
important. Other factors being constant, a higher threshold will increase 
sensitivity and at the same time decrease specificity. Setting the SpO2 
cutoff value closer to the normal level will decrease the number of false-
negative screening results at the cost of increasing the number of false-
positive screening results. Conversely, a lower SpO2 threshold will lower 
sensitivity and raise specificity. Although a number of SpO2 thresholds 
have been proposed, many investigators believe that an SpO2 of  <95% is 
appropriate. One study suggested that SpO2 <92% be considered a 
positive sign of hypoxemia however, others have argued that a low 
threshold is likely to result in a number of infants with critical congenital 
heart disease (CCHD) being misclassified as normal without markedly 
improving specificity
72
. 
PROBE SITE 
Newborns who have obligatory or mixing cyanotic CHD have 
reduced SpO2 both preductally and postductally. Defects with post ductal 
dependent systemic circulation exhibit higher preductal than post ductal 
SpO2 due to right to left shunting of unoxygenated blood to lower body
73
. 
Pulse oximetry screening is thus most effective with postductal probe 
placement. 
 
 
SIGNAL QUALITY AND NEWBORN BEHAVIOUR 
Technical errors are minimized by accepting only high quality 
pulse oximetry signals confirmed by a good pulse signal displayed 
simultaneously.
75,76
 Measurements should not be made when the infant is 
moving, crying, eating or has an apnoeic spell.
66,76
 The heart rate 
displayed by the oximeter should be within the range expected for a calm, 
regularly breathing newborn (about 90–160/min). The highest stable 
SpO2 value, maintained longer than the averaging time of the pulse 
oximetry, is recorded. 
37,74,75 
LIMITATIONS OF PULSE OXYMETRY SCREENING 
There are technical limitations to oximetry measurement in the 
newborn. As noted above, the mean SpO2 in the newborn at 24 hours of 
age is 97% to 98%. However, when continuous pulse oximetry is used, 
multiple investigators have demonstrated periodic and or sustained 
desaturation below 95% during sleep, feeding, and crying.
64,66,69,77
 
Sustained rather than variable hypoxemia is consistent with the diagnosis 
of cyanotic congenital heart disease. Low oximetry readings in the setting 
of normal arterial oxygen saturation have been reported by multiple 
investigators.
78,79
 In fact, falsely low oximetry readings in the newborn 
population are known to be associated with low peripheral perfusion and 
 
 
motion artifact,
80,81
 probe placement site and partial probe detachment
82
 ,  
and hyperbilirubinemia or dyshemoglobinemias. 
There has also been concern that pulse oximeters may not be as 
accurate in darkly pigmented adults and children. At low SpO2 levels 
70%, commercially available oximeters appear to overestimate arterial 
saturation by 3% in darkly pigmented subjects
85
. However, when SpO2 is 
90%, measurement bias related to skin pigmentation appears negligible 
(0.2%). Lastly, the quality of oximetry measurements may be lower when 
performed in a screening setting.
9
 
PULSE OXIMETRY 
The first commercially available pulse oximeter was developed by 
Takuo Aoyagi and was marketed by Nihon Koden in 1974. 
Pulse oximetry is a non-invasive way of measuring the oxygen 
saturation in arterial blood SpO2. A pulse oximeter is based on spectral 
analysis and combines two technologies, spectrophotometry and optical 
plethysmography.
87
   
SPECTROPHOTOMETRY 
A spectrophotometer measures light intensity as a function of the 
colour or more specifically the wavelength of light. There are two classes 
of spectrophotometers, single beam and double beam. Single beam 
spectrophotometer measures the absolute light intensity, whereas double 
 
 
beam spectrophotometer measures the ratio of the light intensity from two 
different light paths. The pulse oximeters use double beam for measuring 
the hemoglobin oxygen saturation. 
OPTICAL PLETHYSMOGRAPHY 
A plethysmograph is a pulse-volume recorder, a way of measure 
the pulsatile changes from the arterial blood at the sensor site. 
PRINCIPLES OF PULSE OXIMETRY TECHNOLOGY 
The principle of pulse oximetry is based on the red and infrared 
light absorption characteristics of oxygenated and deoxygenated 
hemoglobin. Oxygenated hemoglobin absorbs more infrared light and 
allows more red lights to pass through. Deoxygenated (or reduced) 
hemoglobin absorbs more red light and allows more infrared light to pass 
through. Red light is in the 600-750 nm wavelength light band. Infrared 
light is in the 850-1000 nm wavelength light band. 
            Pulse oximetry uses a light emitter with red and infrared LEDs 
that shines through a reasonably translucent site with good blood flow. 
Typical adult and pediatric sites are the finger, toe, pinna (top) or lobe of 
the ear. Infant sites are the foot or palm of the hand and the big toe or 
thumb. Opposite the emitter is a photo detector that receives the light that 
passes through the measuring site. 
 
 
                      The principle of Beer Lambert law is used to measure the 
relative concentrations of  reduced hemoglobin (RHb) and oxygenated 
hemoglobin(O2 Hb) in pulse oximeters. The ratio of light absorbed at the 
red light to that of infrared light A660nm (RHb) / A940 nm (O2 Hb) 
correlates with oxygen saturation, since the concentration of a given 
solute in a solvent is measured by the amount of light that is absorbed by 
the solute at a specific wavelength.
87 
After the transmitted red (R) and 
infrared (IR) signals pass through the measuring site and are received at 
the photodetector, the R/IR ratio is calculated. The R/IR is compared to 
“look-up” tables (made up of empirical formulas) that convert the ratio to 
a SpO2 value. Most manufacturers have their own look-up tables based 
on calibration curves derived from healthy subjects at various SpO2 
levels.
 88
        
                A pulse oximeter can be calibrated in two ways, either 
displaying functional saturation or fractional saturation. 
69,89
 Functional 
saturation is the quantity of Oxyhaemoglobin (HbO2) expressed as a 
percent of haemoglobin that can transport oxygen (since MetHB and 
COHB cannot transport oxygen, they are not included). The functional 
SpO2 value is obtained by multiplying the fractional saturation by 1.02.  
Fractional saturation is the HbO2 expressed as a percent   of all the 
hemoglobin measured, including carboxyhaemoglobin and  
 
 
 
                                     
                     Difference in wavelength of red and infrared light 
 
                   
Light emitter with red and infrared LED being received by 
photodetector which passes through the measuring site. 
 
 
The different tissues affecting light absorption 
 
 
methaemoglobin.
87,90.
 That means that a pulse oximeter calibrated for 
fractional saturation displays about 2% lower values than an oximeter 
calibrated for functional saturation.
69,91 
The calibrations are performed by 
the manufacturer and thus cannot be changed by the user. 
           O2Hb            
       Functional SpO2  =   x 100 
            O2Hb + RHb   
  
                           O2Hb                        
    Fractional SpO2    =            x 100 
              O2Hb + RHb + MetHb + COHb 
The major change that occurred from the oximeters of the 70s to 
the oximeters of today was the inclusion of arterial pulsation to 
differentiate the light absorption in the measuring site due to skin, bone, 
pigmentation and venous blood, from that of arterial blood. The former 
absorbs a constant amount of light over the time. The arteriolar bed 
pulsates and absorbs variable amounts of light during systole (peak) and 
diastole (trough), as blood volume increases and decreases. The ratio of 
light absorbed at the peak and trough is translated into an oxygen 
saturation measurement. Since peaks occur with each heartbeat or pulse, 
the term pulse oximetry was coined.    
                             
 
 
 
 
LIMITATIONS WITH CONVENTIONAL TECHNOLOGY  
PULSE OXIMETRY
92-103 
 Motion artifact (when the patient is moving, the venous blood is also 
moving and the pulse oximeter adds the moving venous blood to the AC 
component, thus the displayed SpO2 is underestimated).  
  Light interference (phototherapy and bright light can affects SpO2 
accuracy).  
 Skin pigmentation (overestimations of SpO2 in dark pigmented skin, as 
skin darkens, the oximeter performance deteriorates. This could be a 
result of empirical calibration data derived from predominantly white 
volunteers).  
 Low peripheral perfusion states  
 Dyshaemoglobinemia (carboxyhemoglobin and methemoglobin are 
unable to carry oxygen.SpO2 readings may appear normal even in the  
hypoxic patient.) 
 Low oxygen saturation  
 Nail polish  
 Irregular heart rhythm  
 Temperature (low peripheral temperature and vasoconstriction 
contributes inaccuracy). 
 
 
                    Still, conventional pulse oximetry accuracy suffered greatly 
during motion and low perfusion and made it difficult to depend on when 
making medical decisions.  The advent of "NEXT GENERATION" 
pulse oximetry technology has demonstrated significant improvement in 
the ability to read through motion and low perfusion
92-103
. 
 
 
     
                                                    
 
 
 
 
 
 
AIM AND OBJECTIVES 
 
 To detect the usefulness of pulse oximetry screening in 
early detection of congenital heart disease (CHD). 
 To evaluate combined pulse oximetry and clinical 
examination as a screening method for congenital heart 
disease (CHD) in asymptomatic newborns. 
 
 
MATERIALS AND METHODS 
 
STUDY DESIGN 
Prospective study 
STUDY PLACE 
Post natal ward, Government Rajaji Hospital, Madurai. 
STUDY PERIOD 
September 2010 to August 2011 
STUDY POPULATION 
New born babies present in postnatal ward of Government Rajaji 
Hospital, Madurai. 
INCLUSION CRITERIA 
ASYMPTOMATIC TERM NEW BORN babies present in post 
natal ward. 
EXCLUSION CRITERIA 
    Sick babies admitted to NICU at birth, Preterm babies, newborn 
babies with prenatal diagnosis of CHD, babies with external congenital 
anomaly were excluded from the study. 
 
 
 
METHODOLOGY 
            This study was a hospital based prospective study. In this study 
we screened asymptomatic term new born babies in the post natal ward 
for congenital heart disease using pulse oximetry and cardiac clinical 
examination between September 2010 and August 2011. 
             Sick babies admitted to NICU at birth, preterm babies, newborn 
babies with prenatal diagnosis of CHD, babies with external congenital 
anomaly were excluded from this study.  
         Asymptomatic term new born babies were screened by pulse 
oximetry using NELLCOR OXIMAX N- 95 HAND HELD NEW 
GENERATION PULSE OXIMETER. Pulse oximetry readings were 
taken in a quiet or sleeping newborn from right foot. The probe was 
cleansed with alcohol swab before each use. 
                The readings were recorded after stabilization for one minute, 
according to the manufacturer instructions. The functional oxygen 
saturation of ≥95% was accepted as normal. If the new born baby had 
oxygen saturation below 90%, echocardiography was performed. In the 
case of a new born with oxygen saturation between 90%-94%, a second 
measurement was performed six hours later. If the oxygen saturation 
remained below 95%, echocardiography was performed. 
 
 
 
 
NELLCOR OXIMAX N – 95 HAND HELD  
NEW GENERATION PULSE OXIMETER 
 
 
 
 
 
 
 
 
 
PULSE OXIMETRY SCREENING 
 
 
 
 
 
 
 
 
 
 
  Cardiac clinical examination screening was also performed for all 
babies simultaneously with pulse oximetry screening. We looked for 
central cyanosis and cardiac murmur. Echocardiography was performed 
for babies having cardiac murmur or central cyanosis.   The cardiac 
clinical examination and pulse oximetry screening were carried out 
between 24 to 48 hours of age.  
           New born babies who underwent echocardiography were 
categorized as  having either a normal heart or a structurally malformed 
heart.  
  
  
    
 
 
 
 
 
 Examination  (murmur,cyanosis)   
STUDY PROTOCOL 
 
 
 
Obtain SpO2 at RT foot in          Cardiac clinical  
Sleeping / quiet neonate  
 
 
 
 
 
 Note highest Value after stabilization 
 for 1 minute  
 
 
 
 
 
SpO2 ≥ 95 %    SpO2 90-94 %        SpO2 < 90 % 
    
 
 
 
    
 
                             
                            Repeat Sp02 after 
                                6 hours later 
   
  
 
 
 
 
               SpO2 ≥ 95 %          SpO2 <95 % 
 
         
 
 
  
No Echocardiography          Echocardiography  
Unless positive clinical 
Exam 
 
 
 
 
OBSERVATION AND RESULTS 
           
 A total of 2437 asymptomatic term newborn babies entered the 
study and they were screened by pulse oximetry and clinical examination. 
Male babies were 1269(52%). Female babies were 1168(48%). Screening 
was performed at a median age of 36 hours. Birth weight ranged from 
2kg to 3.8 kg. Average birth weight was 2.6kg. 24.5% of babies were 
born to consanguineous parents and 75.5% of babies were born to 
nonconsanguineous parents. 50% of babies were of first order. 51.4% of 
babies were delivered by labour naturale. 
Table - 1 
SEX DISTRIBUTION OF SCREENED BABIES 
 
 
 
 
                                                      
 
 
 
 
SEX NUMBER PERCENTAGE 
MALE 1269 52% 
FEMALE 1168 48% 
TOTAL 2437 100% 
 
 
 
52%
48%
SEX DISTRIBUTION OF SCREENED BABIES
Male Female
 
 
 
 
Table - 2 
MODE OF DELIVERY OF SCREENED BABIES 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
                    
 
 
 
 
 
 
 
MODE OF DELIVERY 
 
NUMBER 
 
PERCENTAGE 
NATURAL LABOUR 1254 51.4% 
LSCS 970 39.8% 
OUTLET FORCEPS 165 6.8% 
BREECH 48 2.0% 
TOTAL 2437 100% 
 
 
 
51.4%
39.8%
6.8% 2.0%
MODE OF DELIVERY
NATURAL LABOUR LSCS
OUTLET FORCEPS BREECH
 
 
Table - 3 
PULSE OXIMETRY SCREENING 
 
 
 2,231(91.5%) new borns had oxygen saturation values greater or 
equal to 95%, while 206(8.5%) newborns had oxygen saturation less than 
95%. Out of 206 babies 3 babies had oxygen saturation less than 90%, 
203 babies had oxygen saturation between 90%-94%. Pulse oximetry 
measurements were repeated after 6 hours for the 203 babies. The results 
showed that 21 babies had persistent low oxygen saturation between 90 
to 94% and other 182 babies had oxygen saturation greater or equal to 
95%. A total of 24 babies (1%) required echocardiography because of 
low oxygen saturation values (3 babies-<90%, 21 babies 90-94%). 
Total number of babies screened                                                 
 
2437 
Total number of babies with negative screening (Oxygen 
saturation ≥95%)                                                                 
 
2413 (99%) 
Total number of babies with positive screening (Oxygen 
saturation <95%)                                                                      
 
24(1%) 
Total number of CHD confirmed by Echocardiography in 
babies with positive pulse oximetry screening  
 
17(70.8%) 
Total number of babies with positive pulse oximetry screening 
but having NORMAL HEART confirmed by 
Echocardiography  
 
7(29.2%) 
 
 
            3 echocardiograms were done based on low pulse oximetry value 
< 90%.  One had saturation of 88% and was diagnosed with TRICUSPID 
ATRESIA. Another baby with saturation of 85% was diagnosed as d-
TGA. The third baby had  PULMONARY ATRESIA with a saturation of 
83%. 
           21 Echocardiograms were done based on low pulse oxymetry 
values between 90-94%. Among the 21 babies, one had a saturation of 
91% and was diagnosed with TOF. Another baby with a saturation of 
93% was diagnosed as ASD (OP) with AV canal defect. All other 19 
babies had saturation of 94% and echocardiography results showed 7 
normal hearts, 8 small PDA and 4 small ASD (OS).  
Table - 4 
OXYGEN SATURATION OF BABIES WITH NEGATIVE PULSE 
OXIMETRY SCREENING  (SpO2 > 95%) 
OXYGEN 
SATURATION (%) 
 
NUMBER OF 
BABIES 
PERCENTAGE 
(%) 
95 293 12.1 
96 490 20.3 
97 587 24.3 
98 731 30.3 
99 193 8.0 
100 119 5.0 
TOTAL 2413 100 
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OXYGEN SATURATION OF BABIES WITH NEGATIVE PULSE OXIMETRY SCREENING 
(SpO2 > 95%)
NO.OF CASES PERCENTAGE
 
 
 
   
Table - 5 
OXYGEN SATURATION OF BABIES WITH POSITIVE PULSE 
OXIMETRY SCREENING (SpO2  <95%) 
 
 
 
 
 
                     
 
Table - 6 
ECHOCARDIOGRAPHY RESULT OF BABIES WITH OXYGEN 
SATURATION <90% 
ECHOCARDIOGRAPHY RESULT NUMBER Oxygen 
Saturation 
Tricuspid atresia with ASD (os),PDA, sub 
aortic VSD 
1 88 % 
d-TGA, ASD, PDA 1 85% 
Pulmonary atresia with VSD, PDA 1 83% 
TOTAL 3  
 
 
Oxygen Saturation No.of Babies 
<90% 
 
3 
90%-94% 
 
21 
Total 24 
 
 
 
3
21
OXYGEN SATURATION OF BABIES WITH POSITIVE PULSE OXIMETRY SCREEING  
(SpO2 < 95%)
oxygen saturation < 90%
oxygen saturation < 90%- 94%
 
 
Table - 7 
ECHOCARDIOGRAPHY RESULT OF BABIES WITH OXYGEN 
SATURATION 90%-94% 
 
Table - 8 
ECHOCARDIOGRAPHY RESULTS OF BABIES WITH 
POSITIVE PULSE OXIMETRY SCREENING 
ECHOCARDIOGRAPHY 
RESULT 
NUMBER PERCENTAGE 
CONGENITAL HEART DISEASE 17 71 
NORMAL HEART 7 29 
TOTAL 24 100 
 
     
ECHOCARDIOGRAPHY RESULT NUMBER 
NORMAL HEART 7 
SMALL PDA 8 
SMALL ASD(OS) 4 
LARGE ASD(OP) with AV canal defect 1 
TOF 1 
TOTAL 21 
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OXIMETRY SCREENING
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TOTAL NUMBER OF BABIES 
SCREENED BY PULSE OXIMETRY 
          2437 
SpO2 ≥95% 
   223I 
SpO2<95% 
   206 
SpO2 <90% 
      3 
SpO2 90-94% 
     203 
SpO2 ≥95% 
   182 
SpO2 <95% 
     21 
SpO2 repeated 
after 6 hours 
     203 
  ECHO 
    3 
   ECHO 
   21 
Total Echo 
   24 
      CHD                        NORMAL HEART  
     17                               7 
PULSE OXIMETRY SCREENING 
 
 
Table - 9 
CARDIAC CLINICAL EXAMINATION  
Total number of babies screened 2437 
Total number of babies with negative screening   2401 (98.5% ) 
Total number of babies with positive screening  36(1.4%) 
Total number of CHD confirmed by Echo 
Cardiography in babies with positive clinical 
examination screening  
25(69%) 
Total number of babies with positive clinical 
examination screening but having NORMAL 
HEART confirmed by Echocardiography 
11(31%) 
 
 Cardiac clinical examination screening was performed 
simultaneously with pulse oximetry screening.  Babies were looked for 
murmur and cyanosis. 36 babies had murmur and were considered 
screening positive.  None of the baby had central cyanosis. 
36 echocardiograms were done based on presence of murmur. 
Among the 36 babies, echocardiography showed 10 cases of VSD,          
2 cases of large ASD(OS),1 case of ASD(OP) with AV canal defect,         
3 cases of small ASD, 7 cases of small PDA, 1 case of TOF,  and 1 case 
of isolated dextrocardia. 11 of them showed normal heart.  Among these  
TOF,ASD(OP) with AV canal defect,3 cases of small PDA also had low 
oxygen saturation in addition to murmur.   
 
 
 
 
 
Table - 10 
ECHOCARDIOGRAPHY RESULT OF BABIES WITH POSITIVE 
CLINICAL EXAMINATION 
 
ECHOCARDIOGRAPHY RESULT NUMBER 
NORMAL HEART 11 
VSD 10 
LARGE ASD(OS) 2 
ASD(OP) with AV canal defect 1 
SMALL ASD(OS) 3 
SMALL PDA 7 
TOF 1 
DEXTROCARDIA 1 
TOTAL 36 
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SUMMARY 
In our study 2437 babies were screened by pulse oximetry and 
clinical examination. 31 babies were positive only for clinical 
examination screening. Out of 31, 20 babies had congenital heart 
disease.19 babies were positive only for pulse oximetry screening. Out of 
19, 12 babies had congenital heart disease including 3 life threatening 
cyanotic congenital heart disease. 5 babies were positive for both 
screening tests and all 5 had congenital heart disease. In total, 55 babies 
were screening positive of which 37 babies had congenital heart disease. 
Our study showed that combined screening method identified more 
number of cases with congenital heart diseases than any single method of 
screening.  It was found to be statistically significant. (P value-0.0235)       
Table - 11 
 
SCREENING METHOD NUMBER 
OF 
BABIES 
CHD 
CONFIRMED 
BY ECHO 
NORMAL HEART 
CONFIRMED BY 
ECHO 
Positive only for cardiac 
clinical examination(A) 
31 20 11 
Positive only for pulse 
oximeter(B) 
19 12 7 
Positive for both screening 
test(C) 
5 5 0 
TOTAL NO.OF SCREENING 
POSITIVE BABIES(A+B+C) 
55 37 18 
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SCREENING CHARACTERISTICS OF CHD 
 
 
 
 
 
 
 
 
            
 
 
 
   CHD-37 
SpO2 ≥95% 
        20 
SpO2 90-94% 
          14 
SpO2 <90% 
         3 
        NO 
MURMUR 
     0 
MURMUR 
20 
MURMUR 
      5 
NO 
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3 
        NO 
MURMUR 
      9 
MURMUR 
       0 
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1-DEXTROCARDIA 
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4-SMALL PDA 
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+AV CANAL 
DEFECT 
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1-d-TGA,VSD,PDA 
1-PULMONARY 
ATRESIA,VSD,PDA 
1-TRICUSPID 
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VSD,NO PS 
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PDA 
4-SMALL 
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DISCUSSION 
Some babies born with a cardiac defect may appear healthy soon 
after birth and may be sent home before their cardiac defect is detected.  
These babies are at risk of developing serious complication within the 
first few days or weeks of life and may have significant morbidity and 
mortality. Routine pulse oximetry screening may help in early  
identification of these babies before they land up in complications.   
EFFECTIVENESS OF PULSE OXIMETRY SCREENING 
In this study abnormal pulse oximetry was found in 24 babies of 
which 17 had CHD on echocardiography.5 babies had major CHD [ 1- 
Transposition of the Great Arteries(d-TGA),1- Pulmonary Atresia (PA), 
1- Tricuspid Atresia (TA), 1- Tetralogy of Fallot (TOF), 1-ASD(OP) with 
AV canal defect], 12 babies had minor CHD[4-small ASD, 8-small 
PDA]. Out of 17 CHD babies, 5 babies had murmur [1-TOF,1-ASD(OP) 
with AV canal defect,3-small PDA] and 12 babies had no murmur. 
This study showed that pulse oximetry can detect CHD in 
asymptomatic new born babies which have been missed by routine 
clinical examination. Notably pulse oximetry identified cases of life 
threatening complex cyanotic CHD such as Transposition of great arteries 
(TGA), Tricuspid Atresia (TA), Pulmonary Atresia (PA), none of which 
had been detected clinically. 
 
 
Pure left‐to‐right shunts such as ventricular septal defect, atrial 
septal defect, or patent ductus arteriosus should not be detected by pulse 
oximetry, but some of these defects (5-17%) proved to be screen 
positive.
10,37,75,104
 This happened probably due to bidirectional shunting 
during early postnatal pulmonary hypertension. 
TIME OF PULSE OXIMETRY SCREENING 
If pulse oxymetry screening is performed after a few days of life, 
there will be a reduced incidence of false positives, because of the 
physiologic decrease in the pulmonary vascular resistance, but a newborn 
with a ductal-dependant CHD could deteriorate rapidly if the ductus 
arteriosus had already closed. Measurements performed shortly after birth 
may lead to an increased number of false positives.
10,104,102
  
In this study the babies were screened between 24-48 hours of age 
in the view of early detection of CHD and to decrease the number of false 
positive results. The false positive rate of our study is 0.28% which is 
slightly higher than other studies. This higher false positive rate is due to 
early screening of healthy babies with delayed transitional circulation. 
SATURATION CUT-OFF 
Our decision to use a 95% cut-off was based on published normal 
pulse oximetry values in healthy newborns
66,69
 and saturation differences 
observed in infants with left obstructive heart disease and obligate right to 
 
 
left shunt across the ductus arteriosus.
60
  Pulse oximetry is known to 
overestimate arterial oxygen saturation at low saturations and 
underestimate it at high saturations.
84,65,60 
 The sensitivity and specificity 
remained quite stable using a cut-off ranging from 92% to 95%, whereas 
a cut-off below 92% led to a rapid decrease of sensitivity. 
COMPARISON OF OUR STUDY WITH OTHER PULSE 
OXIMETRY STUDIES 
Comparison with literature is difficult because the study designs, 
methods, target CHD, technical details and way of expressing the results 
are different. 
A case-control study, (Hoke et al; 2002) included 2,972 newborns 
admitted to well baby nurseries and 32 newborns with CHD.  An oxygen 
saturation < 92% in the leg or a saturation 7% lower in the leg than in the 
arm was defined as abnormal. Of the well babies, 57 had an abnormal 
pulse oximetry reading; of these, four babies were found to have 
congenital heart defects, including one case of coarctation of the aorta. A 
fifth baby was found to have pulmonary hypertension. Of the 32 
newborns with congenital heart disease, 11/13 (85%) with left-heart 
obstructive disease had abnormal oxygen saturation as did 15/19 (79%) of 
babies with other congenital heart defects
73
.  
 
 
                 Reich et al; 2003, Babies were assessed with a single pulse 
oximetry reading. Of 2,335 eligible newborns, those with an oxygen 
saturation ≤ 94% that persisted with a second reading were further 
assessed by echocardiogram. An echocardiogram was performed in 88 
infants, which was abnormal in 43 babies, and 13 required management. 
In this study, pulse oximetry was nearly 100% specific for detecting 
cyanotic congenital heart disease; as a result, there was no increase in the 
number of echocardiograms generated
26
.  
 Koppel et al; 2003 assessed the sensitivity, specificity, predictive 
value and accuracy of pulse oximetry screening of 11,281 asymptomatic 
newborns in two hospitals. Diagnostic echocardiogram was performed in 
infants with oxygen saturation ≤ 95% within the first 24 hours of life. 
Three babies with CHD were identified (but none had a critical left-heart 
obstructive lesion). Two patients with negative screens were later 
readmitted; one with aortic coarctation and one with hypoplastic left 
pulmonary artery with aorto-pulmonary collaterals. No unnecessary 
echocardiograms were generated by the study. The sensitivity of the 
screening test was calculated to be 60%, with a specificity of 99.95%, a 
positive predictive value of 75% and a negative predictive value of 
99.98%.
11
 Our study also did not identify critical left heart obstructive 
 
 
lesion like Hypoplastic left heart syndrome, coarctation of aorta, critical 
aortic stenosis. 
  Arlettaz et al; 2006 evaluated the effectiveness of pulse oximetry 
screening to detect structural CHD on the first day of life in all babies 
(n=3,663) born during a one-year period who were > 35 weeks gestation 
and had no respiratory distress. Also evaluated was whether pulse 
oximetry combined with clinical examination is superior to clinical exam 
alone to diagnose CHD. Oxygen saturation readings from one foot were 
considered normal with oxygen saturations > 95%. Twenty-four infants 
had repeated oxygen saturations < 95% and had an echocardiogram. Of 
these, 17 had CHD and five had pulmonary hypertension. One child had a 
myocardial tumour and one infant had a normal heart. No false negative 
cases were reported 
75
. This study showed high detection rate of CHD by 
pulse oximetry.  This may be due to inclusion of babies with CHD 
diagnosed prenatally. 
   Bakr et al: 2005 evaluated combined pulse oximetry and clinical 
examination as a screening method for CHD in all asymptomatic infants 
(excluding those admitted to the neonatal unit) born during a six-month 
period.  Of  5,211 infants, five babies were identified with an oxygen 
saturation <94%, which was considered abnormal. One infant had total 
anomalous pulmonary venous return, one had pulmonary atresia, one had 
 
 
a large ventricular septal defect and another child had a truncus 
arteriosus. The fifth child had a normal heart. Three babies were later 
diagnosed with CHD that was not detected by pulse oximetry screening 
when being investigated for failure to thrive and respiratory symptoms. 
The sensitivity of the combined method of screening was 77%, whereas it 
was 30.8% for oximetry alone and 46% for clinical exam alone, 
Specificity was approximately 100% for all methods. The positive 
predictive value was 80% for pulse oximetry alone 
37
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table - 12 
DETECTION OF CRITICAL CONGENITAL HEART DISEASE  
(CCHD) LESIONS FROM PULSE OXIMETRY SCREENING STUDIES 
 
 
 
CHD Hoke
73
 Richmond
10
 Koppel
11
 Reich
26
 Bakr
37
 Rosati
74
 Arlettaz
75
 Kawalec
53
 Our 
study 
NO OF 
BABIES 
SCREENED 
2876 5626 11281 2114 5211 5292 3262 27200 2437 
DORV 0 0 0 0 0 0 3 0 0 
HLHS 0 0 0 0 0 0 3 2 0 
PA 0 3 0 0 1 0 1 0 1 
d-TGA 1 3 0 1 0 0 2 0 1 
TAPVC 0 0 2 1 1 1 0 1 0 
TRUNCUS 0 0 1 2 1 0 3 0 0 
TA 0 0 0 0 0 0 0 1 1 
AA/AS 0 0 0 0 0 0 1 0 0 
TOF 1 1 0 2 0 0 0 0 1 
AVSD 0 0 0 1 0 0 1 0 0 
CoA 1 2 0 0 0 1 1 3 0 
PS 1 0 0 0 0 0 1 0 0 
TOTAL 4 9 3 7 3 2 16 7 4 
 
 
 
Table – 13 
PULSE OXIMETRY SCREENING STUDIES FOR CRITICAL 
CONGENITAL HEART DISEASE  (CCHD) 
 
 
 
 
 
 
 
 
First 
author 
No of 
babies 
screened 
Age at 
screening 
(h) 
Probe 
location 
Cut off 
normal 
False 
positive 
False 
positive 
rate(%) 
True 
positive 
Hoke
73
 2876 <24 H&F ≥92 53 1.84 4 
Richmond
10 
 5626 11.7 F ≥95 51 0.91 9 
Koppel11 11281 72 F ≥96 1 0.01 3 
Reich 
26
 2114 >24 H&F ≥95 2 0.09 1 
Bakr 
37
 5211 31.7 H&F ≥94 1 0.02 3 
Rosati 
74
 5292 72 F ≥96 1 0.02 2 
Arlettaz
75
 3262 8 F ≥95 7 0.21 17 
Kawalec
53
 27200 26 F ≥95 13 0.05 7 
Meberg
104
 50008 6 F ≥95 324 0.65 43 
Sendelbach
6
 10976 4 F ≥96 636 4.5 0 
Our study 2437 36 F ≥95 7 0.28 4 
 
 
 
EFFECTIVENESS OF CLINICAL EXAMINATION SCREENING 
 In our study 2437 healthy new born babies were screened. Out of 
the 2437 babies 36 had heart murmur. The prevalence of murmur was 
14.8 per 1000 of normal new borns during the period of study. The 
reported prevalence of heart murmur in neonate varies from 6 per 1000 to 
42 per 1000. These variations may be due to the examiner’s skills and 
experience, the timing and frequency of examination, the conditions 
under which examination takes place and the size of population studied
24
. 
   All those babies with murmur underwent echocardiography. CHD 
were detected in 25(69.4%) babies and 11 (30.6%) babies had structurally 
normal heart.  Out of the 25 babies with CHD, 10 (40%) babies had VSD 
which was the common lesion. 
 
 
 
 
 
 
 
 
 
 
 
Table - 14 
COMPARISON OF OUR STUDY WITH OTHER CARDIAC 
CLINICAL EXAMINATION SCREENING STUDIES 
 
Table – 15 
FIRST AUTHOR NO OF BABIES WITH 
CHD 
NO BABIES WITH VSD 
BANSAL
27
 46 19(41.3%) 
LARDHI
25
 61 25(40.9%) 
MEHRDED
35
 47 16(34.0%) 
AINSWORTH
24
 25 15(60.0%) 
OUR STUDY 25 10(40.0%) 
 
 
First author No of 
babies 
screened 
No of babies 
with 
murmur 
Prevalence of  
murmur per 
1000 babies 
Babies with 
CHD  
confirmed by 
ECHO 
Babies with 
normal heart 
confirmed by 
ECHO 
BANSAL
27
 2603 62 23.8 46(74.2%) 16(25.8%) 
LARDHI
25
 6333 87 13.7 61(70.1%) 26(29.9%) 
MEHRDED
35
 2928 91 31.1 47(51.6%) 44(48.4%) 
AINSWORTH
24
 7204 46 6.3 25(54.3%) 21(45.7%) 
OUR STUDY 2437 36 14.8 25(69.4%) 11(30.6%) 
 
 
Tanner et al observed innocent murmur in 44(48.4%) and 
congenital structural heart defects in (51.6%) newborns
38
. Rein et al 
found that 24% of heart murmurs in neonates were innocent.
61
 Another 
study has shown that the prevalence of heart murmur is 13.7 per 1000 
neonates. If a murmur is heard, there is a 42.5% chance of presence of  an 
underlying cardiac malformation.
86
  Yet another study stated that 84% of 
heart murmurs in neonates were caused by heart diseases and only16% 
were innocent and urged subsequent echocardiography.
21
 Many types of 
congenital heart disease may be associated with an asymptomatic 
murmur, the most common being ventricular septal defect (VSD)
27,25,35 
Our study also showed similar results. We found that 30.6% of heart 
murmurs were innocent and 69.4% of heart murmurs had underlying 
CHD ; among them VSD was the most common lesion (40%). 
EFFECTIVENESS OF COMBINED [PULSE OXIMETRY+ 
CLINICAL EXAMINATION] SCREENING 
In this study, we evaluated the efficacy of combining pulse 
oximetry with clinical examination in screening for CHD. In our study, 
CHD was detected in 37 babies (20 babies by clinical examination 
screening +12 babies by pulse oximeter screening +5 babies were 
positive for both screening test). Out of them 25 babies had murmur and 
12 babies had no significant positive clinical examination including 
 
 
murmur, but had abnormal pulse oximetry. Of the 12 babies 3 babies had 
cyanotic congenital heart disease. 
Our study showed that pulse oximetry can detect CHD in 
asymptomatic newborns which was missed by routine clinical 
examination especially life threatening cyanotic congenital heart disease. 
Clinical examination also picked up another group of cases that were 
missed by pulse oximetry. Most of the acyanotic heart diseases were 
detected by means of a murmur.  So the combined approach had an 
additive effect and resulted in more efficient screening. 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 This study indicates that pulse oximetry is a noninvasive, reliable 
and useful screening tool for an early detection of congenital heart 
diseases especially cyanotic congenital heart diseases.  
 The normal oxygen saturation (negative pulse oximetry screening) 
does not rule out CHD especially acyanotic congenital heart disease. 
 The prevalence of murmurs detected at routine examination of 
neonates is 1.48%. 
 About 69.4% murmurs were due to an underlying cardiovascular 
malformation. So detection of a cardiac murmur may be a clue to the 
presence of an underlying heart disease particularly in asymptomatic 
newborn.  
 The absence of a murmur does not exclude serious heart disease. 
 This study concludes that the combination of pulse oximetry and 
clinical examination results in early detection of CHD. Pulse 
oximetry has an additive effect and results in more efficient 
screening. 
 This study suggests that combined screening (pulse oximetry + 
cardiac clinical examination) should be used as a screening method 
for detection of CHD. 
 
 
 
 
 
 
LIMITATIONS 
 
 Small sample size  
 For all babies, a follow up evaluation was not performed. 
 Sensitivity and specificity could not be calculated since 
echocardiography was not performed on screening negative babies 
to know the true negative and false negative cases. 
 
 
 
 
 
 
 
RECOMMENDATIIONS 
 
This study recommends pulse oximetry to be added to 
routine clinical examination as a  screening method for early 
detection of CHD. 
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                                                PROFORMA 
S.NO: 
 
BABY OF: 
 
ADDRESS: 
 
IP.NO: 
 
MOTHER DETAILS: 
AGE(Y) GRAVIDA PARA CONSANGUINITY FAMILY 
H/O CHD 
AN 
SCAN 
INFECTION DM DRUGS 
    YES YES YES YES YES 
NO NO NO NO NO 
 
BABY DETAILS: 
MODE OF DELIVERY 
N/LSCS/FORCEPS/BREECH 
GESTATIONAL AGE 
(TERM/PRETERM) 
DATE OF 
DELIVERY 
TIME OF 
DELIVERY 
SEX 
(M/F) 
WT(KG) 
      
 
SCREENING DETAILS: 
DATE OF SCREENING TIME OF SCREENING BABY AGE AT SCREENING 
1   
2   
 
 
 
CLINICAL EXAMINATION SCREENING: 
CONGENITAL  
ANOMALY 
CYANOSIS TACHYPNEA TACHYCARDIA MURMUR 
YES/NO YES/NO YES/NO YES/NO YES/NO 
 
SCREENING POSITVE SCREENING NEGATIVE 
 
 
PULSE OXIMETRY SCREENING: 
1.  OXYGEN SATURATION (%)  2.  OXYGEN SATURATION(%)  
AFTER 6 HOURS IF NECESSARY 
  
≥95 90-94 <90 ≥95 90-94 <90 
 
SCREENING POSITIVE SCREENING NEGATIVE 
 
ECHOCARDIOGRAPHY RESULTS: 
NORMAL ABNORMAL 
 
ECHOCARDIOGRAPHY DIAGNOSIS: 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
S.NO 
 
 
 
 
 
NAME OF THE BABY 
 
                  MOTHER DETAILS 
 
BABY DETAILS 
 
CLINICAL EXAMINATION 
         PULSE 
OXIMETER READING 
 
 
 
 
 
ECHO RESULT 
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1 B/O Vijaya NCM A N A A A N T F 2.8 A A A - A N 30 88 P TRI ATRESIA 
2 B/O Jones NCM A N A A A L T M 2.8 A A A - A N 38 85 P d-TGA 
3 B/O Chellakani CM A N A A A L T F 2.2 A A A - A N 32 83 P PULATRESIA 
4 B/O Jothi CM A N A A A N T F 2.0 A A A + A P 37 91 P TOF 
5 B/O Isakiselvi CM A N A A A L T F 2.7 A A A + A P 38 97 N VSD 
6 B/O Leelavathi CM A N A A A N T M 2.4 A A A + A P 34 98 N VSD 
7 B/O Panchu NCM A N A A A L T F 2.5 A A A + A P 32 97 N VSD 
8 B/O Jenagai mari NCM A N A A A L T F 3.0 A A A + A P 29 95 N VSD 
9 B/O Sudha NCM A N A A A L T M 2.6 A A A + A P 38 96 N VSD 
10 B/O Jeyalaksmi NCM A N A A A N T M 3.4 A A A + A P 40 98 N VSD 
11 B/O Jansirani CM A N A A A N T M 3.2 A A A + A P 38 99 N VSD 
12 B/O Karthiga NCM A N A A A N T F 2.4 A A A + A P 35 96 N VSD 
13 B/O Sivasakthi NCM A N A A A L T M 2.8 A A A + A P 38 98 N VSD 
14 B/O Mareeswari CM A N A A A L T M 2.3 A A A + A P 30 97 N VSD 
15 B/O Chinaponnu NCM A N A A A L T F 3.0 A A A + A P 37 97 N L-ASD 
16 B/O Thenmozhi NCM A N A A A N T F 3.8 A A A + A P 36 96 N L-ASD 
17 B/OSudha NCM A N A A A N T F 2.7 A A A + A P 31 93 P ASD(OP) 
18 B/O Ramya CM A N A A A N T F 2.4 A A A + A P 38 98 N DEXTROCAR 
19 B/O Pothumponnu NCM A N A A A L T M 2.3 A A A + A P 37 96 N S-ASD 
 
 
 
 
20 B/O Muthulakshmi NCM A N A A A N T M 2.8 A A A + A P 35 96 N S-ASD 
21 B/O Shahirabanu CM A N A A A L T F 2.6 A A A + A P 30 95 N S-ASD 
22 B/O Periyatchi NCM A N A A A L T M 3.1 A A A - A N 32 94 P S-ASD 
23 B/O Lalitha NCM A N A A A N T F 3.7 A A A - A N 30 94 P S-ASD 
24 B/O Kowsalya NCM A N A A A N T F 3.3 A A A - A N 32 94 P S-ASD 
25 B/O Natchiammal CM A N A A A N T F 2.9 A A A - A N 29 94 P S-ASD 
26 B/O Amsavalli NCM A N A A A N T M 2.7 A A A + A P 38 97 N S-PDA 
27 B/O Hemalatha NCM A N A A A N T F 2.5 A A A + A P 35 97 N S-PDA 
28 B/O Kathijabanu NCM A N A A A L T M 2.5 A A A + A P 39 96 N S-PDA 
29 B/O Chithra CM A N A A A N T F 3.0 A A A + A P 35 97 N S-PDA 
30 B/O Jeevitha CM A N A A A L T M 2.8 A A A - A N 31 94 P S-PDA 
31 B/O Nishanthini NCM A N A A A N T F 2.2 A A A - A N 30 94 P S-PDA 
32 B/O Selvamani NCM A N A A A L T M 2.5 A A A - A N 26 94 P S-PDA 
33 B/O Santhi CM A N A A A L T M 2.9 A A A - A N 29 94 P S-PDA 
34 B/O Lalitha NCM A N A A A N T F 3.4 A A A - A N 26 94 P S-PDA 
35 B/O Pandiammal NCM A N A A A N T M 2.7 A A A + A P 28 94 P S-PDA 
36 B/O Murugayee NCM A N A A A N T F 2.4 A A A + A P 25 94 P S-PDA 
37 B/O Devika NCM A N A A A L T F 2.8 A A A + A P 29 94 P S-PDA 
38 B/O Muneeswari NCM A N A A A L T M 2.9 A A A + A P 30 98 N NS 
39 B/O Palanichithra CM A N A A A N T M 2.8 A A A + A P 32 95 N NS 
40 B/O Shanthi NCM A N A A A N T M 2.2 A A A + A P 31 97 N NS 
41 B/O Sudha NCM A N A A A L T F 3.3 A A A + A P 30 96 N NS 
42 B/O Jenifer NCM A N A A A L T M 2.4 A A A + A P 31 98 N NS 
43 B/O Vidhya NCM A N A A A N T M 2.7 A A A + A P 36 97 N NS 
44 B/O Devi CM A N A A A N T M 3.4 A A A + A P 32 96 N NS 
45 B/O Chithra NCM A N A A A N T M 2.9 A A A + A P 29 97 N NS 
46 B/O Jeyanthi CM A N A A A L T F 2.7 A A A + A P 31 97 N NS 
47 B/O Saranya NCM A N A A A N T F 2.6 A A A + A P 33 98 N NS 
48 B/O Selvi NCM A N A A A N T F 2.7 A A A + A P 35 98 N NS 
49 B/O Chinaponnu CM A N A A A L T M 2.5 A A A - A N 29 94 P NS 
50 B/O Muthumari NCM A N A A A L T F 2.8 A A A - A N 30 94 P NS 
 
 
 
 
 
                                                                                                                                                                                                                                                                                          
 
 
                          [CM-consanguineous marriage, NCM-non consanguineous marriage, A-absent, N- natural labor, L-LSCS, T-term, M-male, 
F-female, + present,   - negative, NS-normal study, S-small, L-large, P- Positive Screening,  N-Negative Screening]  
51 B/O Kavitha NCM A N A A A N T F 2.6 A A A - A N 28 94 P NS 
52 B/O Alagu NCM A N A A A N T M 2.4 A A A - A N 31 94 P NS 
53 B/O Muthukili CM A N A A A N T F 2.6 A A A - A N 30 94 P NS 
54 B/O Jeyakodi NCM A N A A A L T F 2.9 A A A - A N 29 94 P NS 
55 B/O Parimalam NCM A N A A A N T M 3.1 A A A - A N 32 94 P NS 
 
 
ABBREVIATIONS 
CHD             Congenital Heart Disease 
CCHD           Critical Congenital Heart Disease 
CHF              Congestive Heart Failure                      
COHb           Carboxy Haemoglobin 
Hb                 Haemoglobin 
RHb              Reduced Haemoglobin or Deoxyhaemoglobin 
IR                 Infra-Red 
LED             Light Emission Diode 
MetHb          Methaemoglobin 
O2Hb           Oxyhaemoglobin 
R                  Red 
AS   Aortic stenosis 
AVSD  Atrio ventricular Septal Defect 
ASD             Atrial Septal Defect 
CoA   Coarctation of Aorta 
DORV  Double outlet right ventricle 
HLHS  Hypoplastic Left Heart Syndrome 
IAA   Interrupted Aortic Arch 
PA                     Pulmonary Atresia 
PDA                   Patent Ductus Arteriosus 
 
 
PFO   Patent Foramen Ovale 
PS                       Pulmonary Stenosis 
TA                       Tricuspid Atresia 
TAPVR  Total Anomalous Pulmonary Venous Return 
TGA                      Transposition of the Great Arteries 
TOF                        Tetralogy of Fallot 
VSD                       Ventricular Septal Defect 
 
 
 
 
 
 
 
 
 
 
 
 
